Today's Research Reports on CRH Medical, Trillium Therapeutics, Sun Life Financial and GeneNews
NEW YORK, NY / ACCESSWIRE / January 16, 2019 /The Market Edge strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://marketedgereport.com and get exclusive access to our numerous research reports and market updates.
The Market Edge Initiates Coverage on:
CRH Medical Corporation
https://marketedgereport.com/report/CRH.TO/
Trillium Therapeutics Inc.
https://marketedgereport.com/report/TRIL.TO/
Sun Life Financial Inc.
https://marketedgereport.com/report/SLF.TO/
GeneNews Limited
https://marketedgereport.com/report/GEN.TO/
CRH Medical's stock moved 0.48% lower Tuesday, to close the day at $4.11. The stock recorded a trading volume of 102,946 shares, which was below its three months average volume of 184,444 shares. In the last year, CRH Medical's shares have traded in a range of 3.09 - 5.91. The share price has gained 33.01% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $4.39 is lower than its 200-day moving average of $4.55. Shares of the company are trading at a Price to Earnings ratio of 48.35. Shares of CRH Medical have fallen approximately 1.67 percent year-to-date.
Access The Market Edge's CRH Medical Corporation Research Report:
https://marketedgereport.com/report/CRH.TO/
On Tuesday, shares of Trillium Therapeutics recorded a trading volume of 10,227 shares, which was above the three months average volume of 5,807 shares. The stock ended the day 6.33% lower at $2.22. The share price has fallen 80.59% from its 52week high with a52 week trading range of 1.99 - 11.44. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $2.76 is lower than its 200-day moving average of $5.44. Shares of Trillium Therapeutics have fallen approximately 5.53 percent year-to-date.
Access The Market Edge's Trillium Therapeutics Inc. Research Report:
https://marketedgereport.com/report/TRIL.TO/
Sun Life Financial's stock moved 0.85% higher Tuesday, to close the day at $47.23. The stock recorded a trading volume of 864,987 shares, which was below its three months average volume of 1,500,433 shares. In the last year, Sun Life Financial's shares have traded in a range of 43.13 - 56.09. The share price has gained 9.51% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $45.89 is lower than its 200-day moving average of $49.74. Shares of the company are trading at a Price to Earnings ratio of 13.44. Shares of Sun Life Financial have gained approximately 4.28 percent year-to-date.
Access The Market Edge's Sun Life Financial Inc. Research Report:
https://marketedgereport.com/report/SLF.TO/
On Tuesday, shares of GeneNews Limited recorded a trading volume of 991,522 shares, which was above the three months average volume of 451,050 shares. The stock ended the day 15.38% lower at $0.055. The share price has fallen 69.44% from its 52week high with a52 week trading range of 0.03 - 0.18. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.039 is lower than its 200-day moving average of $0.057. Shares of GeneNews Limited have gained approximately 10 percent year-to-date.
Access The Market Edge's GeneNews Limited Research Report:
https://marketedgereport.com/report/GEN.TO/
Our Actionable Research on CRH Medical Corporation (TSX:CRH.TO), Trillium Therapeutics Inc. (TSX:TRIL.TO), Sun Life Financial Inc. (TSX:SLF.TO) and GeneNews Limited (TSX:GEN.TO) can be downloaded free of charge at The Market Edge.
The Market Edge
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registeredbroker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute
SOURCE: MarketEdgeReport